Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?

News

Author: Pippa Prendergast-CoatesPublished: 6 August 2020

Prep: Cook: Serves:

Close up woman holding pill in hand with water. Female going to take tablet from headache, painkiller, medication drinking clear water from glass. Healthcare, medicine, treatment, therapy concept

A new study suggests that regular use of non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen may lower the risk of Parkinson’s associated with mutations of the LRRK2 gene – a common genetic cause of the condition.

As part of the study, researchers analysed the data for 577 individuals with the LRRK2 gene mutation. They found that regular use of aspirin and ibuprofen – at least two pills per week for at least six months – was more prevalent in people who did not have Parkinson’s compared to those with the condition. Across the study, the use of NSAIDs corresponded with roughly a 66% decrease in the risk of Parkinson’s.

The researchers say that “the results of this study suggest that the regular use of NSAID medication may lower the risk for Parkinson’s among LRRK2 variant carriers … for both ibuprofen and aspirin” but more research will need to be conducted to find the optimal use.

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.

Does deep brain stimulation for Parkinson’s increase the risk of dementia?

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

Bill Bucklew on walking 2,500 miles for Parkinson’s

Bill Bucklew tells us why he's not afraid of failure

Football stars sign up for Parkinson’s ‘tremor’ campaign

Athletic Bilbao players appear in a viral video

Brush up on your Parkinson’s terminology with this free glossary

Free downloadable and printable A-Z of Parkinson’s disease

Antioxidants could reduce risk of Parkinson’s disease by 32%, study finds

Antioxidant vitamins, found in foods like almonds, avocados and broccoli, could reduce the risk of Parkinson’s disease, researchers in Sweden have reported. The scientists analysed data from a study of 43,865 men and women, aged between 18 and 94. Participants were asked to share information about their diets when the study began and were then monitored through health records over an average of almost 18 years. The researchers found that those who had reported high levels of vitamins C and E – which help prevent cell damage and inflammation – had a 32% lower risk of developing Parkinson’s disease. “Our findings suggest that dietary vitamin E and C intake might be inversely associated with the risk of Parkinson disease,” the scientists concluded.

Weight, sleep and depression linked to risk of cognitive problems in Parkinson’s

Researchers at the University of Pennsylvania, US, have found that people with early Parkinson’s disease are at higher risk of developing cognitive impairments if they are overweight, have disruptive sleep behaviours or experience symptoms of depression. Evaluating data from 405 people, the researchers used statistical analysis to identify relationships between certain characteristics and changes in patient cognition over time. Their findings suggest that factors such as high body mass index (BMI) or excessive sleepiness are associated with a faster rate of cognitive decline in Parkinson’s disease. The researchers wrote: “Despite its common and devastating occurrence, treatment of [cognitive impairments] in [Parkinson’s disease] is limited and no medications slow its onset or progression. However, identification of treatable or modifiable comorbidities that affect the rate of progression of [cognitive impairments] in [Parkinson’s disease] could provide opportunities for early intervention and improved prognosis.”

Gene screening technique could offer insights on Parkinson’s disease

Researchers from the Massachusetts Institute of Technology (MIT), US, will investigate genes that could protect cells in the brain against Parkinson’s disease. An award from US non-profit G Harold and Leila Y Mathers Foundation will allow scientists to use a mouse model screening technique to find out more about the condition. Individually deleting each of the 22,000 genes present in mice neurons will help identify which genes are linked to neuron survival – and offer insights that could lead to new treatments for the condition. Dr Myriam Heiman, an Associate Professor at MIT, said: “There is currently no molecular explanation for the brain cell loss seen in Parkinson’s disease or a cure for this devastating disease. I’m extremely grateful for this generous support and recognition of our work from the Mathers Foundation, and hope that our study will elucidate new therapeutic targets for the treatment and even prevention of Parkinson’s…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?

News

Author: Pippa Prendergast-CoatesPublished: 6 August 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

Bill Bucklew on walking 2,500 miles for Parkinson’s

Europe

Football stars sign up for Parkinson’s ‘tremor’ campaign

Resources & Tools

Brush up on your Parkinson’s terminology with this free glossary

Antioxidants could reduce risk of Parkinson’s disease by 32%, study finds

Weight, sleep and depression linked to risk of cognitive problems in Parkinson’s

Gene screening technique could offer insights on Parkinson’s disease

{title}

Subscribe

Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?

News

Author: Pippa Prendergast-CoatesPublished: 6 August 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

Bill Bucklew on walking 2,500 miles for Parkinson’s

Europe

Football stars sign up for Parkinson’s ‘tremor’ campaign

Resources & Tools

Brush up on your Parkinson’s terminology with this free glossary

Antioxidants could reduce risk of Parkinson’s disease by 32%, study finds

Weight, sleep and depression linked to risk of cognitive problems in Parkinson’s

Gene screening technique could offer insights on Parkinson’s disease

{title}

Subscribe

Sign in